Compare Enact Holdings Inc (ACT) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enact Holdings Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Enact Holdings Inc trades at $49.93 (market cap $6.75B), while State Street SPDR S&P Biotech ETF trades at $158.2. The key difference: Enact Holdings Inc pays a 1.95% dividend while State Street SPDR S&P Biotech ETF pays none, and Enact Holdings Inc is trading nearer its 52-week high, State Street SPDR S&P Biotech ETF nearer its low. Which is the better fit depends on your goals.
| ACT | XBI | |
|---|---|---|
Market Cap | $6.75B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $49.12 | $164.28 |
52-Week Low | $34.93 | $86.92 |
Enterprise Value | $7.05B | — |
Dividend Yield | 1.95% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enact Holdings Inc
Enact Holdings is a leading private mortgage insurance provider in the U.S. It partners with lenders to offer credit enhancement and risk management solutions, helping more borrowers achieve and maintain homeownership.
Read more on ACT →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
